[1]
“THE DARK SIDE OF THE COVID-19 TREATMENTS ON MYCOBACTERIUM TUBERCULOSIS INFECTION”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022021, Feb. 2022, doi: 10.4084/MJHID.2022.021.